Reduced membranous β-catenin protein expression is associated with metastasis and poor prognosis in squamous cell carcinoma of the esophagus

Journal of Thoracic and Cardiovascular Surgery

Volumn 135, Issue 5, 2008, Pages 1029-1035

  Hsu, Po Kuei ^a   Li, Anna Fen Yau ^b   Wang, Yi Ching ^c   Hsieh, Chih Cheng ^a   Huang, Min Hsiung ^a   Hsu, Wen Hu ^a   Hsu, Han Shui ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; PARAFFIN; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; BETA CATENIN; CARCINOMA, SQUAMOUS CELL; CELL MEMBRANE; ESOPHAGEAL NEOPLASMS; FEMALE; GENES, P53; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROGNOSIS; PROTEIN BIOSYNTHESIS;

EID: 43049114228     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2007.11.007     Document Type: Article

References (30)

1. Fahn H.J., Wang L.S., Huang B.S., Huang M.H., and Chien K.Y. Tumor recurrence in long-term survivors after treatment of carcinoma of the esophagus. Ann Thorac Surg 57 (1994) 677-681
2. Doucas H., Garcea G., Neal C.P., Manson M.M., and Berry D.P. Changes in the Wnt signaling pathway in gastrointestinal cancers and their prognostic significance. Eur J Cancer 41 (2005) 365-379
3. Nelson W.J., and Nusse R. Convergence of Wnt, β-catenin, and cadherin pathways. Science 303 (2004) 1483-1487
4. Ilyas M. Wnt signalling and the mechanistic basis of tumour development. J Pathol 205 (2005) 130-144
5. Moon R.T., Kohn A.D., De Ferrari G.V., and Kaykas A. WNT and β-catenin signaling: disease and therapies. Nat Rev Genet 5 (2004) 691-701
6. Ben-Ze'ev A., and Geiger B. Differential molecular interaction of β-catenin and plakoglobulin in adhesion, signaling and cancer. Curr Opin Cell Biol 10 (1998) 629-639
7. Prognostic significance of CyclinD1 and E-Cadherin in patients with esophageal squamous cell carcinoma: multiinstitutional retrospective analysis. Research Committee on Malignancy of Esophageal Cancer, Japanese Society for Esophageal Diseases. J Am Coll Surg 192 (2001) 708-718
8. Conacci-Sorrell M., Zhurinsky J., and Ben-Ze'ev A. The cadherin-catenin adhesion system in signaling and cancer. J Clin Invest 109 (2002) 987-991
9. Brembeck F.H., Rosario M., and Birchmeier W. Balancing cell adhesion and Wnt signaling, the key role of β-catenin. Curr Opin Genet Dev 16 (2006) 51-59
10. Damalas A., Ben-Ze'ev A., Simcha I., Shtutman M., Leal J.F., Zhurinsjy J., et al. Excess β-catenin promotes accumulation of transcriptionally active p53. EMBO J 18 (1999) 3054-3063
11. Harris S.L., and Levine A.J. The p53 pathway: positive and negative feedback loops. Oncogene 24 (2005) 2899-2908
12. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell 88 (1997) 323-331
13. Iwai A., Marusawa H., Matsuzawa S., Fukushima T., Hijikata M., Reed J.C., et al. Siah-1L, a novel transcript variant belonging to the human Siah family of proteins, regulates β-catenin activity in a p53-dependent manner. Oncogene 23 (2004) 7593-7600
14. Levina E., Oren M., and Ben-Ze'ev A. Downregulation of β-catenin by p53 involves changes in the rate of β-catenin phosphorylation and Axin dynamics. Oncogene 23 (2004) 4444-4453
15. Sadot E., Geiger B., Oren M., and Ben-Ze'ev A. Down-regulation of ß-catenin by activated p53. Mol Cell Biol 21 (2001) 6768-6781
16. Greene F.L., Page D.L., Fleming I.D., Fritz A.G., Balch C.M., Haller D.G., et al. AJCC Cancer Staging Manual. 6th ed. (2002), Springer-Verlag, New York
17. de Castro J., Gamallo C., Palacios J., Moreno-Bueno G., Rodriguez N., Feliu J., et al. β-catenin expression pattern in primary oesophageal squamous cell carcinoma. Relationship with clinicopathologic features and clinical outcome. Virchows Arch 437 (2000) 599-604
18. Nair K.S., Naidoo R., and Chetty R. Microsatellite analysis of the APC gene and immunoexpression of E-cadherin, catenin, and tubulin in esophageal squamous cell carcinoma. Hum Pathol 37 (2006) 125-134
19. Takayama T., Shiozaki H., Shibamoto S., Oka H., Kimura Y., Tamura S., et al. β-catenin expression in human cancers. Am J Pathol 148 (1996) 39-46
20. Nakanishi Y., Ochiai A., Akimoto S., Kato H., Watanabe H., Tachimori Y., et al. Expression of E-cadherin, α-catenin, β-catenin and plakoglobin in esophageal carcinomas and its prognostic significance: immunohistochemical analysis of 96 lesions. Oncology 54 (1997) 158-165
21. Takayama N., Arima S., Haraoka S., Kotho T., Futami K., and Iwashita A. Relationship between the expression of adhesion molecules in primary esophageal squamous cell carcinoma and metastatic lymph nodes. Anticancer Res 23 (2003) 4435-4442
22. Zhao X.J., Li H., Chen H., Liu Y.X., Zhang L.H., Liu S.X., et al. Expression of E-cadherin and β-catenin in human esophageal squamous cell carcinoma: relationships with prognosis. World J Gastroenterol 9 (2003) 225-232
23. Kang Y., and Massague J. Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 118 (2004) 277-279
24. Thiery J.P. Epithelial-mesenchymal transitions in tumor progression. Nat Rev Cancer 2 (2002) 442-454
25. Nair K.S., Naidoo R., and Chetty R. Expression of cell adhesion molecules in esophageal carcinoma and its prognostic value. J Clin Pathol 58 (2005) 343-351
26. Zhang G., Zhou X., Xue L., Quan L., Wang Y., Zhou C., et al. Accumulation of cytoplasmic β-catenin correlates with reduced expression of E-cadherin, but not with phosphorylated Akt in esophageal squamous cell carcinoma: immunohistochemical study. Pathol Int 55 (2005) 310-317
27. Shiozaki H., Doki Y., Kawanishi K., Shamma A., Yano M., Inoue M., et al. Clinical application of malignancy potential grading as a prognostic factor of human esophageal cancers. Surgery 127 (2000) 552-561
28. Yamaguchi M., Hirose F., Inoue Y.H., Ohno K., Yoshida H., Hayashi Y., et al. Genetic link between p53 and genes required for formation of the zonula adherens junction. Cancer Sci 95 (2004) 436-441
29. Torbenson M., Kannangai R., Abraham S., Sahin F., Choti M., and Wang J. Concurrent evaluation of p53, β-catenin, and α-fetoprotein expression in human hepatocellular carcinoma. Am J Clin Pathol 122 (2004) 377-382
30. Nozawa N., Hashimoto S., Nakashima Y., Matsuo Y., Koga T., Sugio K., et al. Immunohistochemical α- and β-catenin and E-cadherin expression and their clinicopathological significance in human lung adenocarcinoma. Pathol Res Pract 202 (2006) 639-650